EMPLOYMENT AGREEMENTEmployment Agreement • August 4th, 2020 • Strongbridge Biopharma PLC • Pharmaceutical preparations • Pennsylvania
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made by and between Strongbridge U.S. Inc., a Delaware corporation (the “Company”), and John Johnson (“Executive”) as of July 2, 2020 (the "Effective Date").
TERM LOAN AGREEMENT,Term Loan Agreement • August 4th, 2020 • Strongbridge Biopharma PLC • Pharmaceutical preparations • New York
Schedule 1 - Commitments Schedule 6.01 - Foreign Security Documents Schedule 7.05(b)(i) - Certain Intellectual Property Schedule 7.05(b)(ii) - Intellectual Property Exceptions Schedule 7.05(c) - Material Intellectual Property Schedule 7.06 - Certain Litigation Schedule 7.12 - Information Regarding Subsidiaries Schedule 7.13(a) - Existing Indebtedness of Parent Guarantor and its Subsidiaries Schedule 7.13(b) - Liens Granted by the Obligors Schedule 7.14 - Material Agreements of Obligors Schedule 7.15 - Restrictive Agreements Schedule 7.16 - Real Property Owned or Leased by Parent Guarantor or any Subsidiary Schedule 7.17 - Pension Matters Schedule 9.05 - Existing Investments Schedule 9.10 - Transactions with Affiliates Schedule 9.14 - Permitted Sales and Leasebacks Exhibit A - Form of Assumption Agreement Exhibit B - Form of Notice of Borrowing Exhibit C-l - Form of U.S. Tax Compliance Certificate Exhibit C-2 - Form of U.S. Tax Compliance Certificate Exhibit C-3 - Form of U.S. Tax
WARRANT TO PURCHASE ORDINARY SHARES OF STRONGBRIDGE BIOPHARMA PLC Dated as of May 19, 2020 (the “Issue Date”) Void after the date specified in Section 8Warrant Agreement • August 4th, 2020 • Strongbridge Biopharma PLC • Pharmaceutical preparations • New York
